相关实验视频

Updated: Jan 13, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

在R0切除卵巢癌中生存预测和风险分层:多模式深度学习方法

Yi Zhou¹, Yayang Duan¹, Mingda Teng²

¹Department of Ultrasound, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

NPJ precision oncology

|January 10, 2026

概括

一个新的深度学习模型,OvcaSurvivor,通过整合成像和临床数据,准确地预测卵巢癌的生存率. 这种工具可以改善患者的风险评估,提高精确瘤学和术后护理.

科学领域:

在瘤学瘤学.
人工智能的人工智能
医疗成像医学成像

背景情况:

卵巢癌 (OC) 是妇科癌症死亡的主要原因.
目前的生存预测模型与瘤异质性作斗争,缺乏对个性化风险评估的准确性.

研究的目的:

开发一个新的多式联络深度学习 (DL) 框架,OvcaSurvivor,以改善R0切除卵巢癌患者的生存预测和风险分层.
整合整个幻灯片图像 (WSI),超声波 (美国) 和临床数据,以提高预后准确度.

主要方法:

使用了多式联机DL框架 (OvcaSurvivor),结合了先进的神经网络 (CHIEF用于WSI,ResNet50用于美国) 和注意力引导的融合模块.
在543名R0切除卵巢癌患者的数据上训练并验证了模型,包括内部和两个外部数据集.

主要成果:

OvcaSurvivor表现出高C指数 (0.81内部,0.76外部1,0.70外部2) 的卓越表现.
在1年,3年和5年生存预测的时间依赖AUC中取得了高准确性.
全幻灯片图像特征是关键预测因素,使有效的患者风险分层到高/低风险组.

结论:

多式融合方法推进了卵巢癌的精密瘤学.
OvcaSurvivor为强大的术后管理和个性化的患者护理提供了显著的临床实用性.

更多相关视频

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...